Journal of Cellular Biochemistry · 2019 · 44 citations · 18 references
MedicineCancer BiologyOncologyGene ExpressionMetastasisMolecular OncologyBone MetastasisBone TumorsCancer Cell SignalingMalignant NeoplasmsNoncoding Rna In CancerOncogenic Signaling PathwaysAntisense RnasCancer Cell ApoptosisCancer-related Noncoding Rna FunctionMicrorna Function In CancerNoncoding Rna Expression ProfilingNoncoding Rna In MetastasisPrimary Malignant Bone TumorsTumor Cell Proliferation
Osteosarcoma (OS) is the most common primary malignant bone tumor. Recently, increasing evidence has shown that the long noncoding RNA (lncRNA) DLX6-AS1 (distal-less homeobox 6 antisense 1) plays significant roles in various types of cancers. However, the functions and underlying mechanisms of DLX6-AS1 have not been explored in OS yet. In this study, we assessed the expression of DLX6-AS1 in OS tissues and cell lines and explored the underlying molecular mechanisms. DLX6-AS1 was found to be significantly upregulated in OS tissues and OS cell lines. High expression of DLX6-AS1 was significantly correlated with advanced TNM stage, high tumor grade, and distant metastasis of patients with OS. Knockdown of DLX6-AS1 suppressed OS cell proliferation, invasion, and migration, and induced cell apoptosis. Knockdown of DLX6-AS1 also suppressed in vivo tumor growth. Bioinformatics and luciferase assay analysis showed that DLX6-AS1 functioned as a competing endogenous RNA (ceRNA) to negatively regulate miR-641 expression. Furthermore, miR-641 was found to target the 3' untranslated region of homeobox protein Hox-A9 (HOXA9) and suppressed the expression of HOXA9. Mechanistic studies showed that DLX6-AS1 regulated OS cell proliferation, invasion, and migration via regulating HOXA9 by acting as a ceRNA for miR-641. Our results suggested that DLX6-AS1 functions as a ceRNA by targeting miR-641/HOXA9 signal pathway to suppress OS cell proliferation and metastasis. Our study may provide novel insights into understanding pathogenesis and development of OS.
18
Stefan Bielack, Beate Kempf‐Bielack, G. Delling et al. · Journal of Clinical Oncology · 2002 · 1.8K citations
HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Madhu Kumar, Elena Armenteros-Monterroso, Philip East et al. · Nature · 2013 · 256 citations